NCT07258511
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07258511
Title A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma (TRIlogy-4)
Acronym TRIlogy-4
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR | AUS

Facility Status City State Zip Country Details
Box Hill Hospital RECRUITING Box Hill 3128 Australia Details
Mater Hospital Brisbane RECRUITING South Brisbane 4101 Australia Details
Gold Coast University Hospital RECRUITING Southport 4215 Australia Details
Soroka Medical Center RECRUITING Beersheba 8457108 Israel Details
Bnai Zion Medical Center RECRUITING Haifa 31048 Israel Details
Rambam Medical Center RECRUITING Haifa 3109601 Israel Details
Carmel Medical Center RECRUITING Haifa 34362 Israel Details
Shaare Zedek MC RECRUITING Jerusalem 9103102 Israel Details
Sheba Medical Center RECRUITING Ramat Gan 52621 Israel Details
Baruch Padeh MC RECRUITING Ramat Poriya 1520800 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field